Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients
Poorna Anandavadivelan(Karolinska Institutet), Lena Martin(Karolinska Institutet), Asif Johar(Karolinska Institutet), Torkel B. Brismar(Karolinska University Hospital), Magnus Nilsson(Karolinska University Hospital)
Cited by 179
Related Papers
Gastric cancer
|The Lancet|2020|4.8k
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|646
Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 Update
|Radiology Artificial Intelligence|2024|406